SpineTop Stories

SpineCraft is pleased to announce that Brian Oliver has joined the team as Vice President of US Sales & Marketing

SpineCraft, November 8, 2022 / OrthoSpineNews/ – “With over 20 years of spine sales leadership experience, Brian brings to our team a strong record of developing effective sales organizations and I am confident he will excel in this new position,” said Wagdy Asaad, M.D., SpineCraft President & CEO. “Brian will lead SpineCraft commercial operations to grow the company distribution network and to further strengthen its relationships within the spine surgeon community.”

Brian Oliver
SpineCraft, Vice President of U.S. Sales & Marketing

In his most recent function, Brian was the Vice President of Sales (East) at Innovasis. Prior to that, Brian held various senior and executive sales positions with increasing responsibly at Medacta USA, GS MEDICAL, NuVasive, DePuy Synthes Spine and Ethicon.

About SpineCraft
SpineCraft is a leading medical device company focused on developing, manufacturing and marketing outcome-driven spine surgery systems that provide comprehensive spine care for patients with spine deformities, complex spine problems, degenerative spine conditions and spine trauma. SpineCraft is headquartered in Westmont, Illinois with distribution channels in the US and international markets. For more information, visit www.spinecraft.com.

Contact:
SpineCraft, LLC
630-920-7300
www.spinecraft.com

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button